Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,381,236
+$277,578 QoQ
Shares Held
17,251
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#1,714
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AssuredPartners Investment Advisors, LLC holds $25,676,613 across 8 Drug Manufacturers - General names. JNJ ranks #3 (17.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,352 | $7,618,779 | |
| 2 | ABBV |
AbbVie Inc.
|
25,321 | $6,371,776 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
17,251 | $4,381,236 | |
| 4 | AMGN |
Amgen Inc
|
10,651 | $3,856,940 | |
| 5 | PFE |
Pfizer Inc
|
77,949 | $1,877,011 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,218 | $1,056,013 | |
| 7 | SNY |
Sanofi
|
6,382 | $272,256 | |
| 8 | NVS |
Novartis AG
|
1,548 | $242,602 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,381,236 | 17,251 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,103,658 | 16,788 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,413,657 | 11,663 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,492,445 | 8,049 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $957,437 | 6,268 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,767,522 | 10,658 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,634,784 | 11,304 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||